• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

远程监测对慢性阻塞性肺疾病患者中重度急性加重的影响:丹麦两项随机对照试验的汇总分析

Effect of Telemonitoring on Moderate and Severe Exacerbations in Patients with COPD: Pooled Analysis of Two Randomized Controlled Trials in Denmark.

作者信息

Hyldgaard Charlotte, Ringbæk Thomas, Andersen Frank Dyekjær, Hansen Ejvind Frausing, Jensen Michael Skov, Fenger-Grøn Morten, Trolle Christian, Ulrik Charlotte Suppli

机构信息

Medical Diagnostic Center, University Clinic for Innovative Patient Pathways, Regional Hospital Central Jutland, Silkeborg/Viborg, Denmark.

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

出版信息

Int J Chron Obstruct Pulmon Dis. 2025 Jul 11;20:2361-2369. doi: 10.2147/COPD.S528852. eCollection 2025.

DOI:10.2147/COPD.S528852
PMID:40666254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12262086/
Abstract

BACKGROUND

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are serious events with high morbidity and mortality. Previous studies investigated telemonitoring as a tool for prevention of hospitalizations with ambiguous results. The aim of the present study was to combine data from two randomized controlled trials conducted in Denmark in similar healthcare settings to explore number of hospitalizations for COPD, days of admission, and exacerbations treated outside hospitals.

METHODS

Recruitment took place during hospitalization for AECOPD and from outpatient COPD clinics. Patients were equally randomized to telemonitoring (N=251) in addition to usual care for six months or usual care alone (N=252). We used a negative binomial regression model with between-group comparisons expressed as incidence rate ratios (IRRs) for assessment of hospitalizations, admission days and moderate exacerbations and Kaplan-Meier time-to-event analysis for assessment of time to first COPD hospitalization.

RESULTS

No significant differences between the two studies were identified. In combined analyses, numerically fewer hospitalizations (IRR 0.85, 95% CI 0.62-1.17) and hospitalization days (IRR 0.72, 95% CI 0.42-1.23) were seen in the telemonitoring group, but the findings did not reach statistical significance whereas treatment for moderate exacerbations was significantly more frequent in the telemonitoring group (IRR 1.91, 95% CI 1.49-2.45).

CONCLUSION

No effect of telemonitoring on hospitalizations for AECOPD was documented in this large cohort of patients with severe COPD. However, the telemonitoring group received significantly more treatment for moderate exacerbations. This risk of overtreatment should be considered when telemonitoring is used in the care of patients with COPD.

摘要

背景

慢性阻塞性肺疾病急性加重(AECOPD)是严重事件,具有高发病率和死亡率。既往研究将远程监测作为预防住院的一种工具,但结果不明确。本研究的目的是合并在丹麦类似医疗环境中进行的两项随机对照试验的数据,以探讨慢性阻塞性肺疾病(COPD)的住院次数、住院天数以及院外治疗的急性加重情况。

方法

在AECOPD住院期间和门诊COPD诊所招募患者。患者被随机分为两组,一组(N = 251)除接受六个月的常规治疗外还接受远程监测,另一组(N = 252)仅接受常规治疗。我们使用负二项回归模型,组间比较以发病率比(IRR)表示,用于评估住院次数、住院天数和中度急性加重情况;使用Kaplan-Meier事件发生时间分析评估首次COPD住院时间。

结果

两项研究之间未发现显著差异。在合并分析中,远程监测组在数值上住院次数较少(IRR 0.85,95%CI 0.62 - 1.17)和住院天数较少(IRR 0.72,95%CI 0.42 - 1.23),但这些结果未达到统计学显著性,而远程监测组中度急性加重的治疗明显更频繁(IRR 1.91,95%CI 1.49 - 2.45)。

结论

在这个大量重度COPD患者队列中,未记录到远程监测对AECOPD住院情况有影响。然而,远程监测组接受中度急性加重治疗的次数明显更多。在COPD患者护理中使用远程监测时,应考虑这种过度治疗的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3320/12262086/61be5620da02/COPD-20-2361-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3320/12262086/ae7507e0775e/COPD-20-2361-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3320/12262086/bf76abc1fe12/COPD-20-2361-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3320/12262086/61be5620da02/COPD-20-2361-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3320/12262086/ae7507e0775e/COPD-20-2361-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3320/12262086/bf76abc1fe12/COPD-20-2361-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3320/12262086/61be5620da02/COPD-20-2361-g0003.jpg

相似文献

1
Effect of Telemonitoring on Moderate and Severe Exacerbations in Patients with COPD: Pooled Analysis of Two Randomized Controlled Trials in Denmark.远程监测对慢性阻塞性肺疾病患者中重度急性加重的影响:丹麦两项随机对照试验的汇总分析
Int J Chron Obstruct Pulmon Dis. 2025 Jul 11;20:2361-2369. doi: 10.2147/COPD.S528852. eCollection 2025.
2
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
3
Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病急性加重的简短患者教育行动计划。
Cochrane Database Syst Rev. 2016 Dec 19;12(12):CD005074. doi: 10.1002/14651858.CD005074.pub4.
4
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
5
Antibiotics for exacerbations of chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病急性加重期的抗生素
Cochrane Database Syst Rev. 2012 Dec 12;12:CD010257. doi: 10.1002/14651858.CD010257.
6
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
7
Vitamin D for the management of chronic obstructive pulmonary disease.维生素D用于慢性阻塞性肺疾病的管理
Cochrane Database Syst Rev. 2024 Sep 27;9(9):CD013284. doi: 10.1002/14651858.CD013284.pub2.
8
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
9
Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.硫酸镁治疗慢性阻塞性肺疾病急性加重。
Cochrane Database Syst Rev. 2022 May 26;5(5):CD013506. doi: 10.1002/14651858.CD013506.pub2.
10
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后的肺康复治疗。
Cochrane Database Syst Rev. 2016 Dec 8;12(12):CD005305. doi: 10.1002/14651858.CD005305.pub4.

本文引用的文献

1
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.使用贝那利珠单抗治疗哮喘和慢性阻塞性肺疾病的嗜酸性粒细胞性加重(ABRA):一项双盲、双模拟、活性安慰剂对照的随机试验。
Lancet Respir Med. 2025 Jan;13(1):59-68. doi: 10.1016/S2213-2600(24)00299-6. Epub 2024 Nov 29.
2
A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD.一项关于 COPD 患者口服皮质类固醇治疗相关不良结局的长期研究。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 15;18:2565-2580. doi: 10.2147/COPD.S433326. eCollection 2023.
3
Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial.
英国初级保健中血嗜酸性粒细胞指导下的口服泼尼松龙治疗 COPD 加重(STARR2):一项非劣效性、多中心、双盲、安慰剂对照、随机对照试验。
Lancet Respir Med. 2024 Jan;12(1):67-77. doi: 10.1016/S2213-2600(23)00298-9. Epub 2023 Nov 2.
4
Efficacy and safety of oral corticosteroids to treat outpatients with acute exacerbations of COPD in primary care: a multicentre pragmatic randomised controlled study.口服糖皮质激素治疗基层医疗中慢性阻塞性肺疾病急性加重期门诊患者的疗效和安全性:一项多中心实用随机对照研究。
ERJ Open Res. 2023 Sep 11;9(5). doi: 10.1183/23120541.00057-2023. eCollection 2023 Sep.
5
Effect of telemonitoring on quality of life for patients with chronic obstructive pulmonary disease-A randomized controlled trial.远程监测对慢性阻塞性肺疾病患者生活质量的影响:一项随机对照试验。
Chron Respir Dis. 2023 Jan-Dec;20:14799731231157771. doi: 10.1177/14799731231157771.
6
Effect of telemonitoring on readmissions for acute exacerbation of chronic obstructive pulmonary disease: A randomized clinical trial.远程监测对慢性阻塞性肺疾病急性加重再入院的影响:一项随机临床试验。
J Telemed Telecare. 2024 Oct;30(9):1417-1424. doi: 10.1177/1357633X221150279. Epub 2023 Jan 23.
7
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal.慢性阻塞性肺疾病急性加重的更新定义与严重程度分类:罗马提议
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1251-1258. doi: 10.1164/rccm.202108-1819PP.
8
A Systematic Review and Meta-Analysis of Telemonitoring Interventions on Severe COPD Exacerbations.远程监测干预对重度 COPD 加重的系统评价和荟萃分析。
Int J Environ Res Public Health. 2021 Jun 23;18(13):6757. doi: 10.3390/ijerph18136757.
9
Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits.慢性阻塞性肺疾病急性加重:寻找诊断生物标志物和可治疗特征。
Thorax. 2020 Jun;75(6):520-527. doi: 10.1136/thoraxjnl-2019-214484. Epub 2020 Mar 26.
10
C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations.C 反应蛋白检测指导 COPD 加重期抗生素的使用。
N Engl J Med. 2019 Jul 11;381(2):111-120. doi: 10.1056/NEJMoa1803185.